期刊文献+

1,25羟基维生素D3通过其核受体与膜受体协同调节骨代谢机制的研究进展 被引量:6

原文传递
导出
摘要 1,25羟基维生素D3[1,25-ihydroxyvitamin D3,1,25(OH)2D31是维持机体钙磷离子代谢平衡的主要调节者之一,1,25(OH)2D,缺乏可导致钙质吸收和骨矿化障碍,引起佝偻病的发生:机体钙磷代谢失调可以导致诸如骨质疏松症、骨质软化症等疾病的发生。
出处 《中华骨科杂志》 CAS CSCD 北大核心 2012年第8期788-791,共4页 Chinese Journal of Orthopaedics
  • 相关文献

参考文献32

  • 1Farach-Carson MC, Nemere I. Membrane receptors for vitamin D steroid hormones: potential new drug targets. Curt" Drug Targets, 2003, 4.(1): 67-76.
  • 2Chen J, Olivares-Navan'ete R, Wang Y, et al. Protein-disulfide i- somerase-associated 3 (Pdia3) mediates the membrane response to 1,25-dihydroxyvitamin D3 in osteoblasts. J Biol Chem, 2010, 285 (47): 37041-37050.
  • 3Campbell FC, Xu H, E1-Tanani M, et al. The yin and yang of vi- tamin D receptor (VDR) signaling in neoplastic progression: op erational networks and tissue-specific growth control. Biochem Pharmacol, 2010, 79(1): 1-9.
  • 4Takeyama K, Kato S. The vitamin D3 lalpha-hydroxylase gene and its regulation by active vitamin D3. Biosci Biotechnol Biochem, 2011, 75 (2): 208-213.
  • 5Darwish H, DeLuea HF. Vitamin D-regulated gene expression. Crit Rev Eukaryot Gene Expr, 1993, 3 (2): 89-116.
  • 6St-Arnaud R, Naja RP. Vitamin D metabolism, cartilage and bone fracture repair. Mol Cell Endoerinol, 2011, 347 (1-2): 48-54.
  • 7Farach-Carson MC, Davis PJ. Steroid hormone interactions with target cells: cross talk between membrane and nuclear pathways. J Pharmacol Exp Ther, 2003, 307 (3): 839-845.
  • 8Zanello LP, Norman A. l alpha,25 (OH)2 vitamin D3 actions on ion channels in osteoblasts. Steroids, 2006, 71 (4): 291-297.
  • 9Lieberherr M. Effects of vitamin D3 metabolites on cytosolic free calcium in confluent mouse osteoblasts. J Biol Chern, 1987, 262 (27): 13168-13173.
  • 10Baran DT, Sorensen AM, Shalhoub V, et al. 1 Alpha,25-dihy- droxyvitamin D3 rapidly increases cytosolie calcium in clonal rat osteosareoma cells lacking the vitamin D receptor. J Bone Miner Res, 1991, 6 (12): 1269-1275.

同被引文献76

  • 1张艳梅.羟基-D_3的生理功能和机理研究[J].山西农业科学,2006,34(2):76-78. 被引量:8
  • 2Holick M F. Resurrection of vitamin D deficiency and rickets [ J ]. J Clin Invest, 2006, 116(8): 2062-2072.
  • 3Holick M F, Chen T C. Vitamin D deficiency: a worldwide problem with health consequences[J]. Am J Clin Nutr, 2008, 87(4) : 1080S - 1086S.
  • 4Visser M, Deeg D J, Puts M T, et al. Low serum concentrations of 25- hydroxyvitamin D in older persons and the risk of nursing home admis- sion[J]. Am J Clin Nutr, 2006, 84(3) : 616 -622.
  • 5Meguid N A, Hashish A F, Anwar M, et al. Reduced serum levels of 25-hydroxy and 1,25-dihydroxy vitamin D in Egyptian children with autism[J]. J Altem Complemer Med, 2010, 16(6) : 641 -645.
  • 6Zittermann A. Vitamin D and disease prevention with special reference to cardiovascular disease[ J]. Prog Biophys Mol Biol, 2006, 92 ( 1 ) : 39 - 48.
  • 7Forman J P, Giovannueei E, Holmes M D, et al. Plasma 25- hydroxyvitamin D levels and risk of incident hypertension [ J]. Hyper- tension, 2007, 49 (5) : 1063 - 1069.
  • 8Bischoff-Ferrari H A, Dietrich T, Orav E J, et al. Higher 25- hydroxyvitamin D concentrations are associated with better lower-ex- tremity function in both active and inactive persons aged > or = 60 y [J]. Am J Clin Nutr, 2004, 80(3) : 752 -758.
  • 9Chapuy M C, Arlot M E, Duboeuf F, et al. Vitamin D3 and calcium to prevent hip fractures in the elderly women[ J]. N Engl J Med, 1992, 327(23) : 1637 - 1642.
  • 10Garland C, Gorham E D, Mohr S B, et al. Vitamin D for cancer pre- vention: global perspective[J]. Ann Epidemiol, 2009, 19(7) : 468 - 483.

引证文献6

二级引证文献32

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部